Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Your choice should reflect your financial situation, insurance coverage status, and preference for convenience
Asia-Pacific Asia-Pacific captured 19% share of the Liraglutide and Semaglutide market in 2024 and is projected to be the fastest-growing region during the forecast period
Zepbound (tirzepatide) is an FDA approved weight loss medication that targets both GLP-1 and GIP receptors
Why this matters clinically By combining appetite suppression, improved insulin sensitivity, and increased energy expenditure, retatrutide may represent a next-generation metabolic therapy, rather than a purely appetite-focused agent
US$ 25.60
US$ 23.26
US$ 24.87
US$ 22.13
US$ 24.99
US$ 27.21
